Lateral Flow Assay Market is projected to reach a valuation

The lateral flow assay market is predicted to be worth US$ 4.3 billion in 2023, rising to US$ 6.9 billion by 2033. Throughout the forecast period, lateral flow assay sales are expected to grow at a CAGR of 4.7%.The lateral flow assay (LFA) is a well-known commercial tool in the field of on-site diagnosis because it...

Related Keywords

New York , United States , Delaware , Mexico , United Kingdom , Brazil , Asia Pacific , Eurofins Technologie Rapidscan , Roche Ltd , Human Services , Pharmaceuticals Biotechnology Companies , Quidel Corporation , Market Insights Inc , Greater New York Chamber , Thermo Fisher Scientific Inc , Drug Development Quality Testing , Us Department Of Health , Abbott Laboratories , Danaher Corporation , Rapid Test Device , Segments Covered , Sample Type , End User , Future Market Insights , Market Insights , Sales Channel , End Use , Sales Enquiries , All Reports ,